Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
about
Thrombolytic therapy for pulmonary embolismThrombolytic therapy for pulmonary embolismAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesUpdate on endovascular treatment of peripheral vascular disease: new tools, techniques, and indicationsModern management of pulmonary embolism.Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism.The role of thrombolytic therapy in pulmonary embolismWhen should we thrombolyse patients with pulmonary embolism? A systematic review of the literatureBleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem.Pulmonary embolism--the role of thrombolytic therapy in its managementBolus thrombolytic infusion during prolonged refractory cardiac arrest of undiagnosed cause.Massive pulmonary embolism: review of management strategies with a focus on catheter-based techniques.Acute pulmonary thromboembolism: Epidemiology, predictors, and long-term outcome - A single center experience.Thrombolysis for life-threatening pulmonary embolism 2 days after lung resection.Intra-atrial thrombolytic therapy for dissolution of chronic left atrial thrombi in patients undergoing balloon mitral commissurotomy.Management of pulmonary embolism: state of the art treatment and emerging research.Clinical outcome of patients with suspected pulmonary embolism. A follow-up study of 588 consecutive patients.Systemic thrombolysis in acute pulmonary embolism: also a matter of "time".
P2860
Q24186934-B9FAD6B4-1C98-454D-9BF2-D4FC3B6C5B1DQ24239835-73755394-A787-4F74-BB9D-39522FF7C7E6Q24633053-B22EA227-AA38-48E1-BBF1-2E2C80B54149Q33581071-9C69D8E4-3C3B-43F0-9065-7EAAB9FFA523Q33693996-6B058F65-419E-49DA-B0CF-467D8010230CQ35115224-ABCDAFDE-EC6C-4E0E-B6A4-765BD354D9A6Q35252622-712E5CCA-C080-4351-9D2F-FA68950E11BAQ35345305-C2F7A582-2B4C-4F37-9F7E-755E7C4D9375Q35528953-B2FF06DC-025A-4B93-89C8-3E78F0DF6E09Q36680601-5FE2129E-FAB9-4E2A-AC58-91703E848F1AQ36766327-3D76AB9B-3302-486D-A237-9D250A05560BQ37763204-AC944988-C9CD-42F8-966A-6AEF9801CD9DQ40220003-6EB4DBA3-5930-446E-B5C1-C2832ADA7A32Q40912552-72684920-CD5E-4AD9-BBFC-4C8731C28B01Q44068985-7409C2BC-92DC-436C-A417-D8C085E02A6FQ44304204-F1B1B6B9-18C6-4AC8-96F0-5D2BCF9BE664Q44891035-CA0BA5B0-93B3-4694-BA19-0AF4B989DE34Q51736139-4C3BCAFB-2721-4995-BECC-F6D85219D13E
P2860
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Recombinant tissue-type plasmi ...... controlled multicenter trial.
@en
Recombinant tissue-type plasmi ...... controlled multicenter trial.
@nl
type
label
Recombinant tissue-type plasmi ...... controlled multicenter trial.
@en
Recombinant tissue-type plasmi ...... controlled multicenter trial.
@nl
prefLabel
Recombinant tissue-type plasmi ...... controlled multicenter trial.
@en
Recombinant tissue-type plasmi ...... controlled multicenter trial.
@nl
P2093
P1476
Recombinant tissue-type plasmi ...... controlled multicenter trial.
@en
P2093
C G Elliott
C M Kessler
D B Wilson
D E Heiselman
J A Parker
M L Feldstein
S Z Goldhaber
W R Friedenberg
P356
10.1016/0735-1097(92)90132-7
P407
P577
1992-07-01T00:00:00Z